270 related articles for article (PubMed ID: 38299264)
1. Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review).
Chong Y; Yu D; Lu Z; Nie F
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38299264
[TBL] [Abstract][Full Text] [Related]
2. Atrophic gastritis in Helicobacter pylori-infected children.
Hsieh H; Yang HB; Sheu BS; Yang YJ
Helicobacter; 2022 Jun; 27(3):e12885. PubMed ID: 35306717
[TBL] [Abstract][Full Text] [Related]
3. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
Halldórsdóttir AM; Sigurdardóttrir M; Jónasson JG; Oddsdóttir M; Magnússon J; Lee JR; Goldenring JR
Dig Dis Sci; 2003 Mar; 48(3):431-41. PubMed ID: 12757153
[TBL] [Abstract][Full Text] [Related]
4. Metaplasia in the Stomach-Precursor of Gastric Cancer?
Kinoshita H; Hayakawa Y; Koike K
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953255
[TBL] [Abstract][Full Text] [Related]
5. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori.
Yoshizawa N; Takenaka Y; Yamaguchi H; Tetsuya T; Tanaka H; Tatematsu M; Nomura S; Goldenring JR; Kaminishi M
Lab Invest; 2007 Dec; 87(12):1265-76. PubMed ID: 18004396
[TBL] [Abstract][Full Text] [Related]
6. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
7. Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori.
Shimizu T; Choi E; Petersen CP; Noto JM; Romero-Gallo J; Piazuelo MB; Washington MK; Peek RM; Goldenring JR
J Pathol; 2016 Aug; 239(4):399-410. PubMed ID: 27125972
[TBL] [Abstract][Full Text] [Related]
8. Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter pylori to Expand Its Intragastric Niche.
Sáenz JB; Vargas N; Mills JC
Gastroenterology; 2019 Jan; 156(1):160-174.e7. PubMed ID: 30287170
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and potential therapeutic mechanism of Weiwei decoction on Spasmolytic polypeptide-expressing metaplasia in Helicobacter pylori-infected and Atp4a-knockout mice.
Hong X; Li H; Lin Y; Luo L; Xu W; Kang J; Li J; Huang B; Xu Y; Pan H; Guo S
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117062. PubMed ID: 37598768
[TBL] [Abstract][Full Text] [Related]
10. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
11. Guilt by association: intestinal metaplasia does not progress to gastric cancer.
Graham DY; Zou WY
Curr Opin Gastroenterol; 2018 Nov; 34(6):458-464. PubMed ID: 30138135
[TBL] [Abstract][Full Text] [Related]
12. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
14. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice.
Nomura S; Baxter T; Yamaguchi H; Leys C; Vartapetian AB; Fox JG; Lee JR; Wang TC; Goldenring JR
Gastroenterology; 2004 Aug; 127(2):582-94. PubMed ID: 15300590
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation.
Benedetti I; Hoyos J; Barrios L
Rev Esp Patol; 2020; 53(2):79-87. PubMed ID: 32199598
[TBL] [Abstract][Full Text] [Related]
16. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and intestinal metaplasia of gastric mucosa.
Satarkar RP; Sawant P; Nanivadekar S; Shroff C
Indian J Gastroenterol; 1997 Jan; 16(1):16-7. PubMed ID: 9167374
[TBL] [Abstract][Full Text] [Related]
18. Histological changes associated with pyloric and pseudopyloric metaplasia after Helicobacter pylori eradication.
Wada Y; Kushima R; Kodama M; Fukuda M; Fukuda K; Okamoto K; Ogawa R; Mizukami K; Okimoto T; Murakami K
Virchows Arch; 2020 Oct; 477(4):489-496. PubMed ID: 32356024
[TBL] [Abstract][Full Text] [Related]
19. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
20. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
